Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amphetamine-Dextroamphetamine vs RxWell for Long-COVID Cognitive Fog
NCT05597722Phase 4Terminated
- Start
- Apr 2023
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dextroamphetamine + amphetamine in post acute COVID-19 syndrome. Started Apr 2023; status: terminated.
02
Drugs
dextroamphetamine + amphetamine
03
Conditions
post acute COVID-19 syndrome
Beyond the preview
Go deeper on NCT05597722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05597722.